<qa>  To assess toxicities with addition of bevacizumab to each platinum-doubletI. To assess toxicities with the addition of bevacizumab to each platinum-doublet cisplatindocetaxel, carboplatindocetaxel, cisplatinfluorouracil 5-FU, carboplatin5-FU. 